Modernising quality assurance for clinical grade rare disease pipelines
By
Luke Paul Buttigieg
on
Delivering genomic research at national scale requires more than accurate science. It also requires confidence that every change we make to a pipeline behaves exactly as expected. This blog shares how we modernised our approach to quality assurance, reduced release testing time by over 60%, and built a more sustainable method to pipeline development.
